POS-442 DISCOVERY OF CHK-336: A FIRST-IN-CLASS, LIVER-TARGETED, SMALL MOLECULE INHIBITOR OF LACTATE DEHYDROGENASE FOR THE TREATMENT OF PRIMARY HYPEROXALURIA
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI